Stoke Therapeutics, Inc. (STOK)
32.57
+2.10
(+6.89%)
USD |
NASDAQ |
Dec 10, 10:11
Stoke Therapeutics Research and Development Expense (TTM): 117.76M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Biogen, Inc. | 1.524B |
| Janux Therapeutics, Inc. | 115.15M |
| Insmed, Inc. | 695.91M |
| Sarepta Therapeutics, Inc. | 1.389B |
| Aldeyra Therapeutics, Inc. | 35.99M |